US2008182320A1PendingUtilityA1
Two-step immunization procedure against chlamydia infection
Est. expiryDec 4, 2018(expired)· nominal 20-yr term from priority
A61P 43/00A61P 31/04A61P 27/02A61P 31/00A61K 2039/51A61P 15/00C12N 15/87C07K 14/295A61K 39/00
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A host is immunized against infection by a strain of Chlamydia by initial administration of an attenuated bacteria harbouring a nucleic acid encoding a Chlamydia protein followed by administration of a Chlamydia protein in ISCOMs. This procedure enables a high level of protection to be achieved.
Claims
exact text as granted — not AI-modified1 - 18 . (canceled)
19 . An attenuated strain of an auxotrophic bacterium harbouring a vector comprising a nucleic acid molecule encoding a major outer membrane protein (MOMP) of a strain of Chlamydia and a promoter operatively coupled to said nucleic acid molecule for expression of MOMP by cells of a host to which the strain is administered but not by said attenuated bacteria.
20 . (canceled)
21 . The attenuated strain of claim 19 wherein said strain of Chlamydia is a strain of Chlamydia pneumoniae.
22 . The attenuated strain of claim 19 wherein said strain of Chlamydia is a strain of Chlamydia trachomatis.
23 . (canceled)
24 . The attenuated strain of claim 19 wherein said promoter is a cytomegalovirus promoter.
25 . The attenuated strain of claim 19 wherein said vector is a plasmid vector.
26 . The attenuated strain of claim 25 wherein said plasmid vector is pcDNA3/MOMP as seen in FIG. 5 .
27 . The attenuated strain of claim 19 wherein said attenuated bacteria is an attenuated strain of Salmonella.
28 . The attenuated strain of claim 27 wherein said attenuated strain of Salmonella is an attenuated strain of Salmonella typhimurium.
29 - 40 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.